Genmab — Juni 2018
-
Vedr. de studier af JNJ-283 der står som nye på CT: der er forskellige datoer i spil. Klikker man på Key rekord dates ses en dato for “First submitted” og en dato for “First posted”. First submitted er “study sponsor submitted a study rekord to Clinical Trial.gov, mens “First posted” er “study record available on CT”. For NCT 03551782 var First Submitted d. 30/5 mens First posted var d. 11/6. For NCT var First submitted d. 24/5 mens det blev “posted” d. 6/6. Så der er nogle ugers forsinkelse!!
-
@Roy. Tak for svar. Der er nok mange her der ikke kan finde ud af Genmab's/ jnj's ageren i disse tider. Det burde vel være ret simpelt at sige at " this is not a final decision " og så komme med en forklaring hvad der nu skal ske. Markedet reagerer altid negativt på tvivls spørgsmål. Og er der noget Genmab ikke har brug for nu er det tvivl.
-
Nogen der er oppe til at lytte med kl 0100? http://ir.genmab.com/events.cfm
-
JNJ webcast with president Janssen oncology Tom Cavenaugh
president immunology scott white
http://www.investor.jnj.com/releasedetail.cfm?ReleaseID=1068667 -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind